Most Popular Articles

Sexual activity and function assessment in middle-aged Chinese women using the female sexual function index

Zhang, Caiyun; Cui, Liping; Zhang, Lizhi; More

Menopause. 24(6):669-676, June 2017.

Open

The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN)

El Khoudary, Samar R.; Greendale, Gail; Crawford, Sybil L.; More

Menopause. 26(10):1213-1227, October 2019.

Open

Short-term impact of surgically induced menopause on cognitive function and wellbeing in women at high risk for ovarian cancer following risk-reducing bilateral salpingo-oophorectomy

Chang, Heidi; Kamara, Daniella; Bresee, Catherine; More

Menopause. 28(4):354-359, April 2021.

Physical performance in relation to menopause status and physical activity

Bondarev, Dmitriy; Laakkonen, Eija K.; Finni, Taija; More

Menopause. 25(12):1432-1441, December 2018.

Open
SDC

The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women

Moral, Eloy; Delgado, Juan L.; Carmona, Francisco; More

Menopause. 25(12):1418-1423, December 2018.

Open

The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?

Miller, Virginia M.; Naftolin, Fredrick; Asthana, Sanjay; More

Menopause. 26(9):1071-1084, September 2019.

Open

Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review

Constantine, Ginger D.; Graham, Shelli; Lapane, Kate; More

Menopause. 26(7):800-807, July 2019.

Open
SDC

The MATE survey: men's perceptions and attitudes towards menopause and their role in partners’ menopausal transition

Parish, Sharon J.; Faubion, Stephanie S.; Weinberg, Marc; More

Menopause. 26(10):1110-1116, October 2019.

Open
SDC

The role of physical activity in the link between menopausal status and mental well-being

Bondarev, Dmitriy; Sipilä, Sarianna; Finni, Taija; More

Menopause. 27(4):398-409, April 2020.

Open
SDC

Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause

Portman, David J.; Kaunitz, Andrew M.; Kazempour, Kazem; More

Menopause. 21(10):1082-1090, October 2014.

Open
SDC

Hormone therapy as a possible solution for postmenopausal women with nocturia: results of a pilot trial

Pauwaert, Kim; Goessaert, An-Sofie; Ghijselings, Lynn; More

Menopause. 28(5):502-510, May 2021.

Free
SDC

Effect of sex hormones on coronavirus disease 2019: an analysis of 5,061 laboratory-confirmed cases in South Korea

Lee, Jae Hoon; Kim, Yong Chan; Cho, Si Hyun; More

Menopause. 27(12):1376-1381, December 2020.

Open
SDC

Sexual functioning in 4,418 postmenopausal women participating in UKCTOCS: a qualitative free-text analysis

Harder, Helena; Starkings, Rachel M.L.; Fallowfield, Lesley J.; More

Menopause. 26(10):1100-1009, October 2019.

Open
SDC

Cognitive changes during the menopausal transition: a longitudinal study in women with and without HIV

Maki, Pauline M.; Springer, Gayle; Anastos, Kathryn; More

Menopause. 28(4):360-368, April 2021.

What providers need to know about progestogens in hormone therapy

Liu, James H.

Menopause. 28(3):325-326, March 2021.

Free

A prospective study of the relationships between change in body composition and cardiovascular risk factors across the menopause

Dehghan, Aaron; Vasan, Senthil K.; Fielding, Barbara A.; More

Menopause. 28(4):400-406, April 2021.

Open
SDC

The many menopauses: searching the cognitive research literature for menopause types

Edwards, Hannaford; Duchesne, Annie; Au, April S.; More

Menopause. 26(1):45-65, January 2019.

Open

Early and surgical menopause associated with higher Framingham Risk Scores for cardiovascular disease in the Canadian Longitudinal Study on Aging

Price, Madison A.; Alvarado, Beatriz E.; Rosendaal, Nicole T.A.; More

Menopause. 28(5):484-490, May 2021.

Open
SDC

Vaginal estrogen: a dual-edged sword in postoperative healing of the vaginal wall

Ripperda, Christopher M.; Maldonado, Pedro Antonio; Acevedo, Jesus F.; More

Menopause. 24(7):838-849, July 2017.

Open
SDC

Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy

Wang, Yiwei; Hernandez, Gerson; Mack, Wendy J.; More

Menopause. 27(1):57-65, January 2020.

Open
SDC

Pharmacodynamic effects of the fetal estrogen estetrol in postmenopausal women: results from a multiple-rising-dose study

Coelingh Bennink, Herjan J.T.; Verhoeven, Carole; Zimmerman, Yvette; More

Menopause. 24(6):677-685, June 2017.

Open

Tissue selective estrogen complex (TSEC): a review

Pickar, James H.; Boucher, Matthieu; Morgenstern, Diana

Menopause. 25(9):1033-1045, September 2018.

Open

Brain functional changes in perimenopausal women: an amplitude of low-frequency fluctuation study

Liu, Ningning; Zhang, Yue; Liu, Shuang; More

Menopause. 28(4):384-390, April 2021.

Open

High-density lipoprotein cholesterol and arterial calcification in midlife women: the contribution of estradiol and C-reactive protein

Swabe, Gretchen; Matthews, Karen; Brooks, Maria; More

Menopause. 28(3):237-246, March 2021.

Free
SDC

The 2017 hormone therapy position statement of The North American Menopause Society

The North American Menopause Society

Menopause. 24(7):728-753, July 2017.

Take the CME Test
Buy

Dairy intake is not associated with improvements in bone mineral density or risk of fractures across the menopause transition: data from the Study of Women's Health Across the Nation

Wallace, Taylor C.; Jun, Shinyoung; Zou, Peishan; More

Menopause. 27(8):879-886, August 2020.

Open
SDC

Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial

Hirschberg, Angelica Lindén; Sánchez-Rovira, Pedro; Presa-Lorite, Jesús; More

Menopause. 27(5):526-534, May 2020.

Open
SDC

Systemic estradiol levels with low-dose vaginal estrogens

Santen, Richard J.; Mirkin, Sebastian; Bernick, Brian; More

Menopause. 27(3):361-370, March 2020.

Open

Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules)

Lobo, Rogerio A.; Liu, James; Stanczyk, Frank Z.; More

Menopause. 26(7):720-727, July 2019.

Open

Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA)

Santoro, Nanette; Waldbaum, Arthur; Lederman, Samuel; More

Menopause. 27(12):1350-1356, December 2020.

Open
SDC

Association between osteoporosis and menopause in relation to SOX6 rs297325 variant in Taiwanese women

Hsu, Tzu-Liang; Tantoh, Disline Manli; Chou, Ying-Hsiang; More

Menopause. 27(8):887-892, August 2020.

Open

Improved periodontal disease and prevention of tooth loss in osteoporosis patients receiving once-yearly zoledronic acid: a randomized clinical trial

Taguchi, Akira; Shiraki, Masataka; Tanaka, Satoshi; More

Menopause. 26(11):1277-1283, November 2019.

Open
SDC

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial

Archer, David F.; Goldstein, Steven R.; Simon, James A.; More

Menopause. 26(6):611-621, June 2019.

Open
SDC

Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials

Simon, James A.; Portman, David J.; Kaunitz, Andrew M.; More

Menopause. 20(10):1027-1035, October 2013.

Free

Prescribing of FDA-approved and compounded hormone therapy differs by specialty

Constantine, Ginger D.; Archer, David F.; Graham, Shelli; More

Menopause. 23(10):1075-1082, October 2016.

Open
SDC

What's in a name: are menopausal “hot flashes” a symptom of menopause or a manifestation of neurovascular dysregulation?

Miller, Virginia M.; Kling, Juliana M.; Files, Julia A.; More

Menopause. 25(6):700-703, June 2018.

Open

Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society

Manson, JoAnn E.; Ames, Jeffrey M.; Shapiro, Marla; More

Menopause. 22(3):247-253, March 2015.

Free

Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10 μg estradiol vaginal tablets

Derzko, Christine M.; Röhrich, Sebastian; Panay, Nick

Menopause. 28(2):113-118, February 2021.

Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial

Trower, Mike; Anderson, Richard A.; Ballantyne, Elizabeth; More

Menopause. 27(5):498-505, May 2020.

Open

Effects of stretching on menopausal and depressive symptoms in middle-aged women: a randomized controlled trial

Kai, Yuko; Nagamatsu, Toshiya; Kitabatake, Yoshinori; More

Menopause. 23(8):827-832, August 2016.

Open

The genitourinary syndrome of menopause

Phillips, Nancy A.; Bachmann, Gloria A.

Menopause. 28(5):579-588, May 2021.

Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy

Pickar, James H.; Bon, Charles; Amadio, Julia M.; More

Menopause. 22(12):1308-1316, December 2015.

Open

Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations

Maki, Pauline M.; Kornstein, Susan G.; Joffe, Hadine; More

Menopause. 25(10):1069-1085, October 2018.

Age at natural menopause and physical functioning in postmenopausal women: the Canadian Longitudinal Study on Aging

Velez, Maria P.; Alvarado, Beatriz E.; Rosendaal, Nicole; More

Menopause. 26(9):958-965, September 2019.

Open
Erratum

WISDOM survey: attitudes and behaviors of physicians toward vulvar and vaginal atrophy (VVA) treatment in women including those with breast cancer history

Kingsberg, Sheryl A.; Larkin, Lisa; Krychman, Michael; More

Menopause. 26(2):124-131, February 2019.

Open

Maintaining cognitive function in surgically menopausal women: the importance of estrogen

Kaunitz, Andrew M.; Kapoor, Ekta; Faubion, Stephanie

Menopause. 28(4):349-351, April 2021.

Transitioning to the menopausal transition: a scoping review of research on the late reproductive stage in reproductive aging

Woods, Nancy Fugate; Mitchell, Ellen Sullivan; Coslov, Nina; More

Menopause. 28(4):447-466, April 2021.

Menopause, the gut microbiome, and weight gain: correlation or causation?

Becker, Sarah L.; Manson, JoAnn E.

Menopause. 28(3):327-331, March 2021.

A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause

Fraser, Graeme L.; Lederman, Samuel; Waldbaum, Arthur; More

Menopause. 27(4):382-392, April 2020.

Open
SDC

Subcutaneous testosterone-letrozole therapy before and concurrent with neoadjuvant breast chemotherapy: clinical response and therapeutic implications

Glaser, Rebecca L.; York, Anne E.; Dimitrakakis, Constantine

Menopause. 24(7):859-864, July 2017.

Open

The severity of vasomotor symptoms and number of menopausal symptoms in postmenopausal women and select clinical health outcomes in the Women's Health Initiative Calcium and Vitamin D randomized clinical trial

Nudy, Matthew; Jiang, Xuezhi; Aragaki, Aaron K.; More

Menopause. 27(11):1265-1273, November 2020.

Genitourinary syndrome of menopause: the unmet need

Spadt, Susan Kellogg; Larkin, Lisa C.

Menopause. 28(4):444-446, April 2021.

Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis

Atsma, Femke; Bartelink, Marie-Louise E. L.; Grobbee, Diederick E.; More

Menopause. 13(2):265-279, March-April 2006.

Improvement in sleep outcomes with a 17β-estradiol–progesterone oral capsule (TX-001HR) for postmenopausal women

Kagan, Risa; Constantine, Ginger; Kaunitz, Andrew M.; More

Menopause. 26(6):622-628, June 2019.

Open

The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society

Menopause. 27(9):976-992, September 2020.

Take the CME Test
Buy

A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom

Kroll, Robin; Archer, David F.; Lin, Yuhua; More

Menopause. 25(2):133-138, February 2018.

Open

Determination of estradiol and progesterone content in capsules and creams from compounding pharmacies

Stanczyk, Frank Z.; Niu, Chunying; Azen, Colleen; More

Menopause. 26(9):966-971, September 2019.

Open
SDC

Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause

Pinkerton, JoAnn V.; Joffe, Hadine; Kazempour, Kazem; More

Menopause. 22(1):50-58, January 2015.

Open

Compounded bioidentical hormone therapy: new recommendations from the 2020 National Academies of Sciences, Engineering, and Medicine

Stuenkel, Cynthia A.

Menopause. 28(5):576-578, May 2021.

Treatment with a dual amylin and calcitonin receptor agonist improves metabolic health in an old, obese, and ovariectomized rat model

Katri, Anna; Reker, Ditte; Karsdal, Morten A.; More

Menopause. 28(4):423-430, April 2021.

Open

Femtech and midlife women's health: good, bad, or ugly?

Faubion, Stephanie S.

Menopause. 28(4):347-348, April 2021.

Effects of combined 17β-estradiol and progesterone on weight and blood pressure in postmenopausal women of the REPLENISH trial

Black, Denise R.; Minkin, Mary Jane; Graham, Shelli; More

Menopause. 28(1):32-39, January 2021.

Open

Timing and type of menopause and risk of cardiovascular disease

Hickey, Martha; Mishra, Gita D.

Menopause. 28(5):477-479, May 2021.

Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action

Prague, Julia K.; Roberts, Rachel E.; Comninos, Alexander N.; More

Menopause. 25(8):862-869, August 2018.

Open

The effects of mindfulness and relaxation training for insomnia (MRTI) on postmenopausal women: a pilot study

Garcia, Marcelo C.; Kozasa, Elisa H.; Tufik, Sergio; More

Menopause. 25(9):992-1003, September 2018.

The experiences and needs of Asian women experiencing menopausal symptoms: a meta-synthesis

Shorey, Shefaly; Ng, Esperanza D.

Menopause. 26(5):557-569, May 2019.

The Women's Health Initiative trials of menopausal hormone therapy: lessons learned

Manson, JoAnn E.; Bassuk, Shari S.; Kaunitz, Andrew M.; More

Menopause. 27(8):918-928, August 2020.

Cognitive behavior therapy for menopausal symptoms (CBT-Meno): a randomized controlled trial

Green, Sheryl M.; Donegan, Eleanor; Frey, Benicio N.; More

Menopause. 26(9):972-980, September 2019.

Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms

Simon, James A.; Kaunitz, Andrew M.; Kroll, Robin; More

Menopause. 26(5):506-512, May 2019.

Open

Combined exercise reduces arterial stiffness, blood pressure, and blood markers for cardiovascular risk in postmenopausal women with hypertension

Son, Won-Mok; Sung, Ki-Dong; Cho, Jae-Min; More

Menopause. 24(3):262-268, March 2017.

The association between hormone therapy and sarcopenia in postmenopausal women: the Korea National Health and Nutrition Examination Survey, 2008-2011

Kim, Sung-Woo; Kim, Rebecca

Menopause. 27(5):506-511, May 2020.

Open

Early onset of action with a 17β-estradiol, softgel, vaginal insert for treating vulvar and vaginal atrophy and moderate to severe dyspareunia

Constantine, Ginger; Millheiser, Leah S.; Kaunitz, Andrew M.; More

Menopause. 26(11):1259-1264, November 2019.

Open

Gabapentin for the treatment of hot flushes in menopause: a meta-analysis

Yoon, Sang-Hee; Lee, Ji Young; Lee, Chulmin; More

Menopause. 27(4):485-493, April 2020.

Cycle and hormone changes during perimenopause: the key role of ovarian function

Burger, Henry G.; Hale, Georgina E.; Dennerstein, Lorraine; More

Menopause. 15(4):603-612, July-August 2008.

Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society

Menopause. 22(11):1155-1174, November 2015.

Take the CME Test
Buy

A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial

Paraiso, Marie Fidela R.; Ferrando, Cecile A.; Sokol, Eric R.; More

Menopause. 27(1):50-56, January 2020.

A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause

Biehl, Colton; Plotsker, Olivia; Mirkin, Sebastian

Menopause. 26(4):431-453, April 2019.

Habitual physical exercise has beneficial effects on telomere length in postmenopausal women

Kim, Jung-Ha; Ko, Jae-Hong; Lee, Duk-chul; More

Menopause: The Journal of The North American Menopause Society. 19(10):1109-1115, October 2012.

Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society

Menopause: The Journal of The North American Menopause Society. 20(9):888-902, September 2013.

Lifetime estrogen exposure and cognition in late life: the Cache County Study

Matyi, Joshua M.; Rattinger, Gail B.; Schwartz, Sarah; More

Menopause. 26(12):1366-1374, December 2019.

Efficacy and safety of endocrine therapy for breast-cancer prevention in high-risk premenopausal or postmenopausal women: a Bayesian network meta-analysis of nine randomized controlled trials

Sun, Rong; Chu, Yan; Gao, Yan; More

Menopause. 28(5):589-600, May 2021.

Menopause and exercise

Grindler, Natalia M.; Santoro, Nanette F.

Menopause. 22(12):1351-1358, December 2015.

lncRNA HEIH accelerates cell proliferation and inhibits cell senescence by targeting miR-3619-5p/CTTNBP2 axis in ovarian cancer: Erratum

Menopause. 28(5):601, May 2021.

Free

Dietary changes associated with improvement of metabolic syndrome components in postmenopausal women receiving two different nutrition interventions

Rodriguez-Cano, Ameyalli; Mier-Cabrera, Jennifer; Balas-Nakash, Margie; More

Menopause. 22(7):758-764, July 2015.

Open

When are the most vulnerable, more vulnerable to cognitive changes during the menopause transition?

Looby, Sara E.

Menopause. 28(4):352-353, April 2021.

Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study

Gentry-Maharaj, Aleksandra; Karpinskyj, Chloe; Glazer, Clara; More

Menopause. 22(4):384-390, April 2015.

Open
SDC

Protocol for development of a core outcome set for menopausal symptoms (COMMA)

Kim, Bobae V.; Iliodromiti, Stamatina; Christmas, Monica; More

Menopause. 27(12):1371-1375, December 2020.

Open
SDC

Efficacy of progestin-only treatment for the management of menopausal symptoms: a systematic review

Dolitsky, Shelley N.; Cordeiro Mitchell, Christina N.; Stadler, Sarah Sheehan; More

Menopause. 28(2):217-224, February 2021.

Depression, anxiety, and fear of death in postmenopausal women

Ozdemir, Kevser; Sahin, Sevil; Guler, Dondu Sevimli; More

Menopause. 27(9):1030-1036, September 2020.

Genitourinary syndrome of menopause and age: a new algorithm for hormonal treatment?

Phillips, Nancy A.; Bachmann, Gloria A.

Menopause. 28(2):109-110, February 2021.

The short-term effects of estradiol, raloxifene, and a phytoestrogen in women with perimenopausal depression

Schmidt, Peter J.; Wei, Shau-Ming; Martinez, Pedro E.; More

Menopause. 28(4):369-383, April 2021.

#Menopause on Instagram: a mixed-methods study

Arseneau, Morgan E.; Backonja, Uba; Litchman, Michelle L.; More

Menopause. 28(4):391-399, April 2021.

Can walking exercise programs improve health for women in menopause transition and postmenopausal? Findings from a scoping review

Sydora, Beate C.; Turner, Cailey; Malley, Alexandra; More

Menopause. 27(8):952-963, August 2020.

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health

Faubion, Stephanie S.; Larkin, Lisa C.; Stuenkel, Cynthia A.; More

Menopause. 25(6):596-608, June 2018.

Take the CME Test
Buy

The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society

Menopause. 12(5):497-511, September-October 2005.

The 2017 hormone therapy position statement of The North American Menopause Society

Menopause. 25(11):1362-1387, November 2018.

Women's experience of vulvovaginal symptoms associated with menopause

Shifren, Jan L.; Zincavage, Rebekah; Cho, Ellen L.; More

Menopause. 26(4):341-349, April 2019.

Effects of menopause on sleep quality and sleep disorders: Canadian Longitudinal Study on Aging

Zolfaghari, Sheida; Yao, Chun; Thompson, Cynthia; More

Menopause. 27(3):295-304, March 2020.

Hypertension in menopausal women: the effect and role of estrogen

Srivaratharajah, Kajenny; Abramson, Beth L.

Menopause. 26(4):428-430, April 2019.

Login

Register for a free account

In Brief:

In Brief:

In Brief: